FDA Investigator Michelle L Johnson
Michelle L Johnson has conducted inspections on 30 sites in 4 countries as of 15 Jan 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
30
Last Inspection Date:
15 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Mexico,
United States of America,
Germany,
Belgium
FDA Investigators that have inspected at least one site in common with Michelle L Johnson:
Amy M Cramer,
Ana S Cabrera,
Brian S Keefer,
Bruce W Benware,
Bryce A May,
Carol Henderson,
Catherine J Laufmann,
Christina D Mello,
Daniel R Tammariello,
Darin S Wiegers,
Dave M Deroche,
David H Smith,
Denise M Visco, Investigator,
Dolores Harper,
Dorathy M Eischen,
Edward D Mcdonald,
Eric J Cunningham,
Erica R Woody,
Frank J Marciniak,
Garrad R Poole,
Gobiga Vanniyasingam,
Jacob M Dyer,
James A Lane,
James M Odonnell,
James P Stallings,
Jesse A Vazquez,
Jessica D Spellman,
Jin M Kim,
John A Daubenspeck,
Joseph M Allen,
Joseph R Strelnik,
Karen F Tomaziefski,
Kelly I Anderson,
Kinh Q Mac,
Kristina J Donohue,
Kwong P Lee,
Laura A Munsterman,
Lauren L Vajo,
Laurie B Frazier,
Li Li,
Lisa D Cash,
Loretta Nemchik,
Margaret M Sands,
Martha Sullivan Myrick,
Melissa A Freeman,
Melissa A Zuppe,
Meredith L Sheridan,
Michael J Nerz,
Michael Serrano,
Michelle J Hines,
Nicholas Fragedakis,
Nicholas L Hunt,
Norman Wong,
Robert G Ruff,
Ronald A Stokes,
Ronda Rloyd Jones,
Stephen C Smith,
Steven E Kane,
Tania E Vizcaino,
Thai T Duong,
Trushani T Desai,
William R Chang,
Yung W Chan
Michelle L Johnson's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2022 | FDA 483 | Mytamed Inc - Form 483, 2022-06-27 |
August, 2021 | FDA 483 | Blickman Industries LLC - Form 483, 2021-08-20 |
March, 2020 | FDA 483 | Becton Dickinson & Company - Form 483, 2020-03-17 |
November, 2019 | FDA 483 | Lingraphicare America, Inc. - Form 483, 2019-11-15 |
January, 2020 | FDA 483 | MSR Imports, Inc. - Form 483, 2020-01-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more